Pulmozyme and Multi-therapy Approach
Pulmozyme is often a component of a Multi-therapy Approach in the management of cystic fibrosis 15-19
Every prescribed therapy plays an important role in managing the destructive cycle of cystic fibrosis by targeting different disease mechanisms 15-19
A multi-therapy approach targets different disease mechanisms
NOTE: In several pivotal phase 3 trials assessing the efficacy and safety of CFTR modulators, patients continued to receive their Pulmozyme treatment15-19
Controlling mucus is an essential component in the management of cystic fibrosis 7
3. Harms HK et al. Dnase International Study Group. Multicenter, open-label study of recombinant human Dnase in cystic fibrosis patients with moderate lung disease. Pediatr Pulmonol. 1998; 23(3): 155-161;
4. King, M. Mucolytics and mucus clearance. In Rubin BK, van der Sxhans CP, eds. Therapy for Mucus-Clearance Disorders. New Yoirk, NY: Marcel Dekker Inc, 2004:201-224;
5. Chmiel, JF, Kanstan MW. Anti-inflammatory medication for cystic fibrosis lung disease: selecting the most appropriate agent. Treat Respir Med. 2005; 4(4):255-273;
6. Puchelle E et al. Physical and functional properties of airway secretions in cystic fibrosis – therapeutic approaches. Respiration. 1995; 62(suppl 1) 2-12;
7. Lyczak, JB et al. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2—2; 15(2):194-222.
15. Orkambi summary of product characteristics. Vertex Pharmaceuticals (Europe) Ltd.
16. Wainwright CE et al. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N Engl J Med. 2015;373(3):220-231.
17. Ramsey BW et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365(18):1663-1672.
18. Davies JC. Et al. Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. Am J Respir Crit Care Med. 2013;187(11):1219-1225.
19. Kalydeco summary of product characteristics. Vertex Pharmaceuticals (Europe) Ltd.
20. Cystic Fibrosis Foundation. Patient Registry Annual Data Report 2015. https://www.cff.org/Our-Research/CF-Patient-Registry/2015-Patient-Registry-Annual-Data-Report. Accessed April 3, 2017.
21. Clancy JP. Ongoing research into CFTR modulation. Adv Stud Med. 2010;10(1):14-18.
22. Bennet, WD et al. Hydrator therapies for chronic bronchitis: lessons from cystic fibrosis. Ann Am Thorac Soc. 2016;13(2):S186-S190.
Video: Cystic Fibrosis Foundation. Treatment and Therapies. https://www.cff.org/Life-with-CF/Treatments-and-Therapies/
All Countries
Select a Country
Argentina
Australia
Austria
Belarus
Belgium
Bolivarian Republic Of Venezuela
Bosnia and Herzegovina
Brazil
Bulgaria
Canada
Chile
Colombia
Costa Rica
Curaçao
Croatia
Cyprus
Czech Republic
Denmark
Dominican Republic
Ecuador
El Salvador
Estonia
Finland
France
Germany
Guatemala
Greece
Honduras
Hong Kong
Hungary
Ireland
Iceland
Israel
Italy
Jamaica
Japan
Kuwait
Latvia
Lebanon
Lithuania
Luxembourg
Macao
Macedonia
Malta
Mexico
Netherlands
New Zealand
Nicaragua
Norway
Oman
Panama
Paraguay
Peru
Poland
Portugal
Romania
Russian Federation
Serbia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
Trinidad and Tobago
Turkey
Ukraine
United Kingdom
United States
Uruguay
Argentina
Local HCP Portal: https://www.dialogoroche.com/ar/home/sitios_de_productos/info_para_preescribir.html
Request Medical Information: https://medinfo.roche.com/
Australia
http://www.roche-australia.com/
Local HCP Portal: https://www.rocheinteract.com.au/medicine-and-resources/Pulmozyme.html
Request Medical Information: https://medinfo.roche.com/
Austria
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Belarus
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Belgium
Local HCP Portal: https://www.rochepro.be/nl_be/wetenschappelijke-bijsluiters/pulmozyme.html
Request Medical Information: https://medinfo.roche.com/
Bolivarian Republic Of Venezuela
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Bosnia and Herzegovina
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Brazil
Local HCP Portal: https://www.dialogoroche.com/br/home/produtos/pulmozyme.html
Request Medical Information: https://medinfo.roche.com/
Bulgaria
Local HCP Portal: https://www.rochemd.bg/bg_bg/products1/respiratory/pylmozyme.protected.html
Request Medical Information: https://medinfo.roche.com/
Canada
Local HCP Portal : http://www.rochecanada.com/en/content/products_database/consumer-information/pulmozyme.html
Request Medical Information: https://medinfo.roche.com/
Chile
Local HCP Portal: https://www.dialogoroche.com/mx/home/info_para_preescribir.html
Request Medical Information: https://medinfo.roche.com/
Colombia
Local HCP Portal: https://www.dialogoroche.com/mx/home/info_para_preescribir.html
Request Medical Information: https://medinfo.roche.com/
Costa Rica
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Curaçao
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Croatia
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Cyprus
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Czech Republic
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Denmark
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Dominican Republic
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Ecuador
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
El Salvador
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Estonia
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Finland
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
France
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Germany
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Guatemala
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Greece
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Honduras
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Hong Kong
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Hungary
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Ireland
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Iceland
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Israel
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Italy
Local HCP Portal: https://www.infomedics.it/it_it/products/pulmozyme.protected.html
Request Medical Information: https://medinfo.roche.com/
Jamaica
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Japan
https://www.chugai-pharm.co.jp
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://contact.chugai-pharm.co.jp/
Kuwait
http://www.roche-middleeast.com/
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Latvia
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Lebanon
http://www.roche-middleeast.com/
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Lithuania
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Luxembourg
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Macao
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Macedonia
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Malta
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Mexico
Local HCP Portal: https://www.dialogoroche.com/mx/home/info_para_preescribir.html
Request Medical Information: https://medinfo.roche.com/
Netherlands
This website is not intended for Dutch healthcare professionals. For further information, please visit: https://www.roche.nl
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
New Zealand
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Nicaragua
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Norway
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Oman
http://www.roche-middleeast.com/
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Panama
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Paraguay
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Peru
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Poland
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Portugal
Local HCP Portal: https://www.rochenet.pt/pt_pt/medicamentos-roche/lista-de-medicamentos-roche/pulmozyme-alfa-dornase.protected.html
Request Medical Information: https://medinfo.roche.com/
Romania
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Russian Federation
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Serbia
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Singapore
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Slovakia
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Slovenia
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
South Africa
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Spain
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Sweden
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Switzerland
Local HCP Portal: www.roche-online.ch/de_ch/ppmsselfdetail.html#home
Request Medical Information: https://medinfo.roche.com/
Trinidad and Tobago
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
Turkey
Local HCP Portal: https://www.medikaynak.com/u/pulmozyme
Request Medical Information: https://medinfo.roche.com/
Ukraine
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
United Kingdom
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/
United States
Local HCP Portal Pulmozyme content : https://www.pulmozyme.com/
Request Medical Information: https://www.gene.com/contact-us/submit-medical-inquiry
Uruguay
Local HCP Portal Pulmozyme content not available
Request Medical Information: https://medinfo.roche.com/